Afghanistan vs Iran, Islamic Republic of: Treatment success rate for patients treated for MDR-TB
Afghanistan
72.0%
in 2022
Iran, Islamic Republic of
72.0%
in 2022
Afghanistan rank
87th
Iran, Islamic Republic of rank
87th
Treatment success rate for patients treated for MDR-TB over time
- Afghanistan
- Iran, Islamic Republic of
How they compare
Afghanistan currently reports 72.0% against 72.0% in Iran, Islamic Republic of, a difference of 0.0%.
The two have swapped places 4 times across 12 shared years of data; in 2011 it was Iran, Islamic Republic of ahead.
Afghanistan ranks 87th and Iran, Islamic Republic of ranks 87th of 163 countries.
Afghanistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Iran, Islamic Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.2% | 59.9% | 6.3% | Afghanistan |
| 2020s | 71.3% | 68.3% | 3.0% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Afghanistan or Iran, Islamic Republic of?
- Afghanistan, at 72.0% against 72.0% in Iran, Islamic Republic of as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Afghanistan and Iran, Islamic Republic of?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Iran, Islamic Republic of?
- 12 years are reported by both, from 2011 to 2022.
- How do Afghanistan and Iran, Islamic Republic of rank globally for treatment success rate for patients treated for mdr-tb?
- Afghanistan ranks 87th and Iran, Islamic Republic of ranks 87th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.